BioXcel Therapeutics to Host Virtual Neuroscience R&D Day on Dec. 12, 2023
NEW HAVEN, Conn., Nov. 30, 2023 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced that it will host a virtual Neuroscience R&D Day from 1:00 to 2:30 p.m. ET on Tuesday, Dec. 12, 2023.
- NEW HAVEN, Conn., Nov. 30, 2023 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced that it will host a virtual Neuroscience R&D Day from 1:00 to 2:30 p.m.
- He has published nearly 900 articles and 44 books devoted to neuroscience, Alzheimer’s disease, and clinical trials.
- To access the virtual R&D Day presentation, please dial 877-407-5795 (domestic) or 201-689-8722 (international).
- BioXcel Therapeutics may use its website as a distribution channel of material information about the Company.